Dr. Daniel Gibbs is on a mission to change attitudes on Alzheimer's after 13 years living with the disease himself.
Here's the important reason why...
There may soon be a new tool available to help doctors more firmly diagnose Alzheimer’s disease, according to the results of a study published recently in JAMA Neurology and conducted in part at the Memory and Aging Program at Butler Hospital.
Alzheimer’s disease has three stages: early (mild), middle (moderate), and late (severe). Here is what to expect and what to do during each of them.
Welcome to the blog of the Memory and Aging Program (MAP) at Butler Hospital. We are a world leader in Alzheimer’s research and a local Rhode Island partner in the fight against Alzheimer’s disease and dementia. To learn more about our research and how to get involved, visit butler.org/memory.
Heroes & Pioneers
How this neuropsychologist has come full circle and full-steam ahead in his career and his quest to help end Alzheimer’s at the Memory and Aging Program at Butler Hospital.
Research & Program News
The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced.
Caregiver to both her young husband and her father with dementia, now she’s supporting others in the caregiver journey.
Join the Alzheimer's Prevention Registry
If you’re aged 40 to 85 and are an individual with normal memory, some memory decline, or mild dementia, you can help in the development of breakthrough tests and treatments for Alzheimer’s. Take just a few moments to enroll in our Alzheimer’s Prevention Registry, a tool that allows us to match up individuals interested in participating in research with studies for which they may qualify – either now or in the future.